SummaryIn a prospective study of 52 consecutive women who required acceleration of labour intravenous prostaglandin E2 (PGE,) was used as the oxytocic agent. These mothers were matched for age, parity, height, gestational age, initial cervical dilatation, and station and position of the fetal head with 52 women whose labours were accelerated with oxytocin; both drugs were equally effective. Acceleration to delivery intervals, second-stage durations, the number of assisted deliveries, and Apgar scores were similar regardless of the oxytocic used.Although PGE2 compares well with oxytocin, it offers no further advantages and is more expensive and less well tried than oxytocin.
SummaryIn a prospective study of 52 consecutive women who required acceleration of labour intravenous prostaglandin E2 (PGE,) was used as the oxytocic agent. These mothers were matched for age, parity, height, gestational age, initial cervical dilatation, and station and position of the fetal head with 52 women whose labours were accelerated with oxytocin; both drugs were equally effective. Acceleration to delivery intervals, second-stage durations, the number of assisted deliveries, and Apgar scores were similar regardless of the oxytocic used.Although PGE2 compares well with oxytocin, it offers no further advantages and is more expensive and less well tried than oxytocin.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.